Related references
Note: Only part of the references are listed.Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
F. H. M. Prince et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
G. Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Treatment strategies for juvenile idiopathic arthritis
Ariane Klein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
Ricardo A. G. Russo et al.
JOURNAL OF RHEUMATOLOGY (2009)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
J Fransen et al.
RHEUMATOLOGY (2004)
The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2003)
Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period
DA Kietz et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
